We modified a protocol which used three different methods and their combination for retrieving specifically anti-Aβ immunoreactivity in AD mouse brains to determine whether it improved Iba1 staining (Kai et al., 2012 [2]; Murayama et al., 1999 [3]). Here, AIF1 is linked to Alzheimer disease.